Identification of a DNA aptamer that inhibits sclerostin's antagonistic effect on Wnt signalling.

about

Molecular Selection, Modification and Development of Therapeutic Oligonucleotide Aptamers Gene therapy for bone engineering.Selection and Characterization of a DNA Aptamer Specifically Targeting Human HECT Ubiquitin Ligase WWP1.

P2860

Q26765458-82CE8ECE-0583-428A-89D8-E9F65A0975CF Q38362703-EEE4CE6F-0057-4137-AE24-1D63C3DA3F89 Q52362632-35DFE9F5-7D88-4A68-834A-7DF08E1DFB6F

P2860

Identification of a DNA aptamer that inhibits sclerostin's antagonistic effect on Wnt signalling.

Item

http://www.wikidata.org/entity/Q38338282

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Identification of a DNA aptame ...... stic effect on Wnt signalling.

@en

type

Item

label

Identification of a DNA aptame ...... stic effect on Wnt signalling.

@en

prefLabel

Identification of a DNA aptame ...... stic effect on Wnt signalling.

@en

P1476

Identification of a DNA aptame ...... stic effect on Wnt signalling.

@en

P2093

Celine Chan

http://www.w3.org/2001/XMLSchema#string

Ching-Man Leung

http://www.w3.org/2001/XMLSchema#string

Julian A Tanner

http://www.w3.org/2001/XMLSchema#string

Ka To Shum

http://www.w3.org/2001/XMLSchema#string

P2860

Quadruplex DNA: sequence, topology and structure

Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)

Osteocyte control of bone formation via sclerostin, a novel BMP antagonist

SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor

Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein

Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist

NMR structure of the Wnt modulator protein Sclerostin

Characterization of the Structural Features and Interactions of Sclerostin: MOLECULAR INSIGHT INTO A KEY REGULATOR OF Wnt-MEDIATED BONE FORMATION

Clustal W and Clustal X version 2.0

Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase

P304

493-501

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1042/BJ20101096

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

434

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21204783

http://www.w3.org/2001/XMLSchema#string

Identification of a DNA aptamer that inhibits sclerostin's antagonistic effect on Wnt signalling.

about

P2860

P2860

Identification of a DNA aptamer that inhibits sclerostin's antagonistic effect on Wnt signalling.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698